Reference
Agenzia Italiana del Farmaco (AIFA). Direct communication with healthcare professionals on Xagrid (anagrelide hydrochloride). Internet Document : 24 Feb 2022. Available from: URL: https://www.aifa.gov.it/en/-/nota-informativa-importante-su-xagrid-anagrelide-cloridrato-
Rights and permissions
About this article
Cite this article
AIFA warns of risk of thrombotic events after abrupt discontinuation of anagrelide. Reactions Weekly 1896, 1 (2022). https://doi.org/10.1007/s40278-022-10792-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-10792-3